Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

mucocutaneous leishmaniasis - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

mucocutaneous leishmaniasis

MONDO:0005859

Also known as:American cutaneous leishmaniasisAmerican mucocutaneous leishmaniasisNew World cutaneous leishmaniasis

Find Clinical TrialsTrials

Overview

The most common form of leishmaniasis that is transmitted through the bite of female phlebotomine sand flies or after exposure to leishmania parasites. It is characterized by skin lesions at the site of insect bite which typically develop within weeks or months after exposure. The lesions typically progress from small papules to open sores with raised borders and central ulcers which can be covered with scales or crust.

Clinical Trials1 registered

Diagnosis

Biomarker and diagnostic research for mucocutaneous leishmaniasis has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.

90 publications have been identified in PubMed for mucocutaneous leishmaniasis. Research spans Epidemiology / Natural History (26%), Case Report / Case Series (24%), and Basic Science / Preclinical (19%).

Research Type	Count	% of Total
Disease patterns and progression	23

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 1 active clinical trial a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

mucocutaneous leishmaniasis

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications